It's not an macro thing. Even if the macro market moves, Ariad will not move proportionately. The company is trapped. High MC, no more access to capital, huge bloated burn and a clueless CEO with a useless board and 20 something VP's like its EFFIN AMGN.
It does have some value in its drugs to someone who has the capital and knows WTF they are doing.